1Chen J,Liu C.Is sulfasalazine effective in ankylosing spondylitis A sys-tematic review of randomized controlled trials[J].The Journal of Rheuma-tology,2006,35(4):722-731.
2Zhang W,Doherty M,Arden N,et al.EULAR evidence based recommen-dations for the management of hip osteoarthritis.Report of a task force of the EULAR standing committee for international clinical studies in-cluding therapeutics(ESCLSIT)[J].Ann Rheum Dis,2005,64(5):669-681.
5Baraliakos X, Listing J, Fritz C, et al. Persistent clinical ef- ficacy and safety of infliximab in ankylosing Slpondylitis after 8 years-early clinical response predicts long-tern1 outcome[J]. Rheunmtology (Oxford), 20ll, 50(14): 1690.
6常青中西医结合治疗强直性脊柱炎的疗效观察[J].中国中医药咨汛,2011,3(23):303.
7Ranaka Y, Takeuchi T, Mimori T, et al. Discontinuation of infliximab after attaining low disease aetivity in patients with rheumatoid arthritis: RRR (remi,~aion induction by Remicade in (RA) study[J]. Ann Rheum Dis, 2010, 69(11): 1286.
813aronnet L, Barnetche T, Kahn V, et al. Incidence of tu- berculosis in patients with rheumatoid arthritis. A systematic literature review[Jj, joint Bone Spine, 2011, 78(13):279.
9Barkhuizen h, Steinfeld S,Robbins J,et al. Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis[J].J Rheuma- tol,2006,33(9):1805-1812.
